Winning Health Technology Group Co., Ltd. (SHE:300253)
China flag China · Delayed Price · Currency is CNY
6.41
-0.36 (-5.32%)
Oct 30, 2026, 3:04 PM CST

SHE:300253 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
2,2932,1062,7823,1633,0932,750
Revenue Growth
5.90%-24.30%-12.05%2.28%12.46%21.34%
Gross Profit
779.69691.431,1591,4231,3511,275
Operating Income
-262.09-224.19270.25395.7669.54279.34
Net Income
-373.05-373.8887.89357.96108.64378.17
Earnings Per Share
-0.17-0.170.040.160.050.18
EPS Growth
---75.05%221.70%-71.21%-23.34%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Medical and Health Information Industry
1,9272,4452,8492,5282,311
Internet Medical and Health Industry
178.75336.81312.35563.07438.6
Unallocated Other
0.010.442.471.380.37
Total
2,1062,7823,1633,0932,750

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,5181,7621,3391,1141,2821,601
Total Debt
23.781,1501,1311,0981,036936.48
Net Cash (Debt)
1,494611.59207.8315.99245.18664.07
Net Cash Growth
1228.88%194.27%1199.84%-93.48%-63.08%-18.20%
Net Cash Per Share
0.680.280.100.010.110.31

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
573.01555.37407.53184.8100.44368.06
Capital Expenditures
-162.02-220.35-305.82-313.33-323.7-286.23
Free Cash Flow
410.99335.01101.71-128.53-223.2681.83
Free Cash Flow Growth
69.27%229.38%----59.76%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
34.01%32.83%41.65%44.97%43.69%46.35%
Operating Margin
-11.43%-10.64%9.71%12.51%2.25%10.16%
Pretax Margin
-19.04%-21.01%3.13%10.77%1.25%13.57%
Profit Margin
-16.27%-17.75%3.16%11.32%3.51%13.75%
FCF Margin
17.93%15.91%3.66%-4.06%-7.22%2.97%

Dividends

Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period EndingDec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.0150.0200.0100.020
Dividend Per Share Growth
-25.00%100.00%-50.00%-20.00%
Dividend Yield
0.21%0.28%0.10%0.12%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
--176.9542.85201.8895.11
Forward PE
240.3444.1925.5434.44171.3346.38
P/FCF Ratio
34.3357.93152.91--439.53
PS Ratio
6.159.225.594.857.0913.08